Literature DB >> 17699824

Yearly zoledronic acid in postmenopausal osteoporosis.

Ron N J de Nijs, Antonius A A Westgeest.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699824     DOI: 10.1056/NEJMc071514

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Zoledronic acid: a review of its use in the treatment of osteoporosis.

Authors:  Emma D Deeks; Caroline M Perry
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 2.  Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations.

Authors:  John Sunyecz
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.